CRB-556

N/A

Report date: 2025/01/26 16:28:26
NME

Base Information

Drug NameCRB-556
Drug Alias NameCB1 inverse agonists (Corbus Pharmaceuticals)cannabinoid 1 receptor inverse agonists (Corbus Pharmaceuticals)CRB-556
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionCannabinoid CB1 receptor inverse agonists
TargetsCannabinoid CB1 receptor
Therapy Area/IndicationsObesityMetabolic Diseases
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesCorbus Pharmaceuticals Holdings Inc
China Registration ClassN/A

Develop Information

Active CompaniesCorbus Pharmaceuticals Holdings Inc
Inactive CompaniesN/A
Active IndicationsObesityMetabolic Diseases
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A